What is the packaging specification?

Packed in paper drums with two plastic bags inside, with a net weight of 25kgs.

Water-soluble star anise white powder extract shikimic acid

Name: Water-soluble star anise white powder extract shikimic acid
Brand: Xi an Sost Biotech Co., Ltd.
SKU: 1968643685

Shaanxi, ChinaXi an Sost Biotech Co., Ltd.

US$72.80

1 kg

Sample price:US$72.80/kg.Request sample

Product profile

Customization

Available

Certification

ISO, HACCP, Kosher; Hala

Assay Method

GPC, HPLC

Model NO.

Extract Powder

Application Form

Tablet, Capsule

Application

Health Care Products, Medicine

State

Powder

Extract Source

star anise

Transport Package

1. 1 kilogram per Aluminum Foil Bag with one plast

Specification

98%

Trademark

SOST

Origin

China

Production Capacity

5000 Kgs/Month

Key features

Anti-Inflammatory Effects: Provides analgesic and anti-inflammatory benefits by affecting arachidonic acid metabolism.

Avian Flu Intermediate: Key raw material for Tamiflu, the primary antiviral medication against H5N1 bird flu.

Multiple Certifications: Certified by ISO, HACCP, Kosher, and Halal standards for global compliance.

Water Soluble Form: White to off-white powder that is odorless and easily soluble in water.

OEM and ODM Services: Full customization support available for manufacturing and product development.

Rapid Lead Time: Production lead time within 15 workdays for both peak and off-peak seasons.

Strict Quality Control: Heavy metals and microbiological tests strictly controlled to meet safety standards.

Company profile

Xi an Sost Biotech Co., Ltd.

Shaanxi, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2012-11-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.70h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXi'an Sost Biotech Co., Ltd. is identified as a China-based manufacturer and trading company focused on herbal extracts, Chinese medicine raw materials, cosmetic ingredients, healthcare ingredients, food additives, and dietary supplement ingredients. Evidence indicates established production, R&D, sales, purchasing, and quality-control functions, with stated GMP-oriented operations, ISO 9001:2015 certification, multiple production bases, and broad export coverage. However, the records contain conflicting production information: one slice reports three production bases and eight lines, while another reports a 2,990 m² plant and two production lines. The supplier states that it provides pre- and after-sales service and accepts several trade and payment terms, but detailed service performance, customization results, customer references, and financial strength are not sufficiently documented. Monetary figures are omitted.

Supplier typeThe supplier is explicitly classified as a manufacturer and limited company, while another record identifies its business nature as a trading company. Its stated activities include R&D, production, sales, and service of herbal extracts and natural raw materials, so it appears to combine manufacturing and trading functions.

CertificationsThe supplier reports ISO 9001:2015 certification and states that production follows national GMP standards, with GMP-standard factories and 100,000-level clean workshops. ISO certification is explicit; the GMP statements are operational claims rather than a separately named certificate.

After-Sales capabilityThe company explicitly emphasizes before-sales and after-sales service, states that it continuously improves service, and describes service as part of its business operations. However, no evidence gives measurable after-sales performance, service staffing, response times, or documented customer outcomes.

R&D capabilityThe supplier reports an R&D department, research and development of high-purity natural products, biological engineering and natural extraction technology, and an innovation-oriented approach. Nevertheless, only two years of R&D engineer experience are reported, and there is no evidence of patents, new-product records, or quantified R&D achievements.

Production capacityProduction capability is supported by a stated manufacturing plant, natural-extract production activities, GMP-oriented facilities, clean workshops, and product lines covering food, healthcare, cosmetics, and pharmaceutical intermediates. The data are inconsistent: one record states three production bases and eight lines, while another reports a 2,990 m² plant and two lines; quality-control staffing is also reported as fewer than five employees.